Skip to Primary Navigation

Pharmaceutical Compliance Congress: Panelists spot trends to prioritize in 2025

Neil Falkingham at the Pharmaceutical Compliance Congress2025.
GSK CCO Neil Falkingham kicked off the event. Photo: Julie DiMauro

At the annual pharmaceutical compliance event, panelists said the time for an empowered compliance department engaged in mindful monitoring is now.

At the spring 2025 PCC event in McLean, Virginia, speakers had many best practices tips and lessons learned to highlight, but their overall message to attendees was that ethics and integrity matter, data analytics are your friend, ongoing monitoring is expected, and it’s time for compliance to partner with business-line functions.

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience